ALK and non-small cell lung carcinoma: Dysregulated ALK signaling has been extensively implicated in a range of solid tumors, particularly non-small cell lung cancer (NSCLC) [11], anaplastic large cell lymphoma (ALCL) [6], and neuroblastoma (NB) [12].